Menu
Currency
GWAS Study

Locus for severity implicates CNS resilience in progression of multiple sclerosis.

International Multiple Sclerosis Genetics Consortium

37380766 PubMed ID
GWAS Study Type
22389 Participants
57 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

IM
International Multiple Sclerosis Genetics Consortium
Chapter II

Abstract

Summary of the research findings

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) that results in significant neurodegeneration in the majority of those affected and is a common cause of chronic neurological disability in young adults1,2. Here, to provide insight into the potential mechanisms involved in progression, we conducted a genome-wide association study of the age-related MS severity score in 12,584 cases and replicated our findings in a further 9,805 cases. We identified a significant association with rs10191329 in the DYSF-ZNF638 locus, the risk allele of which is associated with a shortening in the median time to requiring a walking aid of a median of 3.7 years in homozygous carriers and with increased brainstem and cortical pathology in brain tissue. We also identified suggestive association with rs149097173 in the DNM3-PIGC locus and significant heritability enrichment in CNS tissues. Mendelian randomization analyses suggested a potential protective role for higher educational attainment. In contrast to immune-driven susceptibility3, these findings suggest a key role for CNS resilience and potentially neurocognitive reserve in determining outcome in MS.

12,584 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

22389
Total Participants
GWAS
Study Type
Yes
Replicated
9,805 European ancestry individuals
Replication Participants
European
Ancestry
Spain, Greece, Canada, Austria, Netherlands, Sweden, U.S., Belgium, Norway, Italy, U.K., Australia, Germany, Denmark
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.